Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib with paclitaxel or olaparib in advanced endometrial carcinoma
NCT03570437Phase 2Unknown
- Sponsor
- The University of Manchester
- Start
- May 2018
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cediranib in endometrial carcinoma, carcinosarcoma, sponsored by The University of Manchester. Status: unknown.
02
Drugs
cediranib
03
Conditions
endometrial carcinomacarcinosarcoma
Beyond the preview
Go deeper on NCT03570437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03570437.